How big is Cidara Therapeutics, Inc.?

Jun 22 2025 06:07 PM IST
share
Share Via
As of Jun 18, Cidara Therapeutics, Inc. has a market capitalization of 286.63 million and reported net sales of 0.30 million with a net profit of -185.60 million over the latest four quarters.
As of Jun 18, Cidara Therapeutics, Inc. has a market capitalization of 286.63 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 0.30 million, while the sum of net profit for the same period is -185.60 million.

As of Dec 24, the shareholder's funds are reported at 163.31 million, and total assets amount to 215.58 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News